LAROCOP 20 MG/ML SUSPENSION FOR INJECTION

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

COPPER (AS COPPER METHIONATE)

Available from:

Chanelle Pharmaceuticals Manufacturing Limited

ATC code:

QA12CX

INN (International Name):

COPPER (AS COPPER METHIONATE)

Dosage:

20 Mg/Ml

Pharmaceutical form:

Suspension for Injection

Prescription type:

LM-Licensed Merchant

Therapeutic group:

Bovine, Ovine

Therapeutic area:

Other mineral products

Therapeutic indications:

Vitamins & Minerals

Authorization status:

Authorised

Authorization date:

1991-10-01

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Larocop 20 mg/ml Suspension for injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Copper (as copper methionate)
20 mg/ml
EXCIPIENT(S):
Chlorocresol (as preservative)
1 mg/ml
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
A sterile blue suspension for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of copper deficiency in cattle and sheep and clinical conditions associated with copper
deficiency.
4.3 CONTRAINDICATIONS
Not to be administered by the intravenous route.
Do not use in animals with known hypersensitivity to the active ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The copper status of animals should be checked pre-treatment. This is particularly important in sheep where overdose
can lead to haemolytic crisis.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 03/01/2017_
_CRN 7024206_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The likelihood of a nodule appearing can be reduced by the use of the proper injection technique.
Shake the vial vigorously to re-suspend the solid prior to use.
Inject into a clean site only in the neck area by deep intramuscular injection.
Avoid injection into the rump muscles.
It is generally advised to avoid injection on wet days as this can increase the likelihood of contamination. The product
should not be administered with other injections.
The dosage and frequency of therapy required depends on the clinical condition and copper status of the ani